TRANSPLANT Act of 2020
Latest action · Dec 14, 2020 Message on Senate action sent to the House.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 18, 2019
- Passed HouseSep 30, 2020
- Passed SenateDec 11, 2020
- To the PresidentNot reached
- Became lawNot reached
Summary
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020
This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.
Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.
In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.
Recorded votes 1
Newest first. Open one to see how every member voted.
Cosponsors 52
Members who signed on, in the order they did. Signatures ran from Oct 18, 2019 to Sep 29, 2020; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-ME | Chellie Pingree | Original | Oct 18, 2019 |
| R-FL | Gus M. Bilirakis | Original | Oct 18, 2019 |
| R-PA | Brian K. Fitzpatrick | Oct 22, 2019 | |
| D-TX | Sheila Jackson Lee | Oct 23, 2019 | |
| R-NC | Ted Budd | Oct 23, 2019 | |
| R-OR | Greg Walden | Oct 28, 2019 | |
| R-AL | Robert B. Aderholt | Oct 28, 2019 | |
| D-FL | Alcee L. Hastings | Nov 12, 2019 | |
| D-CA | Eric Swalwell | Nov 12, 2019 | |
| D-CO | Joe Neguse | Nov 19, 2019 | |
| R-AK | Don Young | Nov 20, 2019 | |
| D-MD | Anthony G. Brown | Dec 3, 2019 | |
| D-VT | Peter Welch | Dec 3, 2019 | |
| D-CA | Harley Rouda | Dec 4, 2019 | |
| D-NC | G. K. Butterfield | Dec 17, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 18, 2019Markup Sep 9, 2020Reported Sep 29, 2020 |
| Health Subcommittee | Referred Oct 21, 2019 |
Actions 18
Everything that happened, newest first.
- Dec 14, 2020Message on Senate action sent to the House.
- Dec 11, 2020Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)
- Dec 11, 2020Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)
- Oct 1, 2020Received in the Senate, read twice.
- Sep 30, 2020Considered as unfinished business. (consideration: CR H5089-5090)
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S7450Amendments S7449, S7450 | Lamar Alexander R-TN (amendment), Mitch McConnell R-KY | Dec 11, 2020 |
| House | Recorded votes H5089enactLists H5090Votes recorded by proxy on H.R. 4764, Timely ReAuthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies (TRANSPLANT) Act | — | Sep 30, 2020 |
| House | Debate and remarks H4996–H4998Text printed H4996 | Christopher H. Smith R-NJ, Frank Pallone, Jr. D-NJ, Greg Walden R-OR, Gus M. Bilirakis R-FL | Sep 29, 2020 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Dec 24, 2020H.R. 4764, TRANSPLANT Act of 2019As ordered reported by the House Committee on Energy and Commerce on September 9, 2020
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 165, October 18, 2019, page H8260.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-123 | IMPROVING ACCESS TO CARE: LEGISLATION TO REAUTHORIZE KEY PUBLIC HEALTH PROGRAMS176 pages | Energy and Commerce Committee | Jul 29, 2020 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R47327 | Suspension of the Rules: House Practice in the 116th Congress (2019-2020) | Report | Dec 7, 2022 |
Amendments 1
Amendments offered to this bill.
| Amendment | Description | Offered by | Status |
|---|---|---|---|
| SA 2704 | In the nature of a substitute. | Lamar Alexander R-TN | Amendment SA 2704 agreed to in Senate by Unanimous Consent. |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3520 | Stem Cell Therapeutic and Research Reauthorization Act of 2019 | Related bill | Jun 27, 2019 |
| S 4672 | TRANSPLANT Act of 2020 | Related bill | Sep 23, 2020 |
Titles 11
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
- Short Titles as Passed Senate
- TRANSPLANT Act of 2020
- Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
- Short Title(s) as Introduced
- TRANSPLANT Act of 2019
- Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019
- Short Title(s) as Reported to House
- TRANSPLANT Act of 2019
- Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019
- Short Title(s) as Passed House
- TRANSPLANT Act of 2020
- Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
- Short Title(s) from Engrossed Amendment Senate bill text
- Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
- TRANSPLANT Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 5
Each version as it was printed, newest first.
- Dec 11, 2020Engrossed Amendment Senate
- Oct 1, 2020Received in Senate
- Sep 30, 2020Engrossed in House
- Sep 29, 2020Reported in House
- Oct 18, 2019Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.